Thermo Fisher Q4 rev $12.21B (+7%), adj EPS $6.57 (+8%); FY rev $44.56B (+4%)

THERMO FISHER SCIENTIFIC INC.

2025-FY EPS reported $17.74 revenue$44,556,000,000

Q4 GAAP diluted EPS $5.21 (+9%); adj EPS $6.57 (+8%); GAAP operating margin 18.5%.
Full-year GAAP EPS $17.74 (+7%); adj EPS $22.87 (+5%); adj operating margin 22.7%.
Revenue growth driven by organic +3% (Q4) and +2% (FY); PPI Business System cited.
Announced $13B M&A in 2025 including Clario deal; returned $3.6B via buybacks/dividends.
2026 financial guidance to be provided on conference call; not included in press release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.